Korean Society of Infectious Diseases/National Evidence-based Healthcare Collaborating Agency Recommendations for Anti-SARS-CoV-2 Monoclonal Antibody Treatment of Patients with COVID-19

Neutralizing antibodies targeted at the receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein have been developed and now under evaluation in clinical trials. The US Food and Drug Administration currently issued emergency use authorizations for neutral...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Infect Chemother
Hauptverfasser: Kim, Sun Bean, Kim, Jimin, Huh, Kyungmin, Choi, Won Suk, Kim, Yae-Jean, Joo, Eun-Jeong, Kim, Youn Jeong, Yoon, Young Kyung, Heo, Jung Yeon, Seo, Yu Bin, Jeong, Su Jin, Yu, Su-Yeon, Peck, Kyong Ran, Choi, Miyoung, Yeom, Joon Sup
Format: Artigo
Sprache:Inglês
Veröffentlicht: The Korean Society of Infectious Diseases; Korean Society for Antimicrobial Therapy; The Korean Society for AIDS 2021
Schlagworte:
Special Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8258293/
https://ncbi.nlm.nih.gov/pubmed/34216134
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2021.0304
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge